Barclays analyst Glen Santangelo maintains Dentsply Sirona (NASDAQ:XRAY) with a Underweight and r

New system completes the Surity™  portfolio of external catheters for both men and women Integrates

Empowered Funds LLC increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 515.3% in the f

DENTSPLY SIRONA NASDAQ: XRAY reported second-quarter 2026 revenue of $898 million, down 4.1% on a re

DENTSPLY SIRONA's Q2 sales fall 4.1% as dental weakness offsets Wellspect growth, while margins impr

The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter

DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript

Dentsply International (XRAY) came out with quarterly earnings of $0.52 per share, beating the Zacks

Dentsply Sirona (NASDAQ:XRAY) affirms FY2026 Adj EPS guidance from $1.40-$1.50 to $1.40-$1.50 vs $1.

Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.52 per share which beat the analyst

News Summary Reported net sales of $898 million Delivered GAAP gross margin of 54.9%, GAAP diluted e

Arkadios Wealth Advisors acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) in

XRAY's Q2 results are likely to reflect transformation investments, dealer inventory cuts and weak i

Dimensional Fund Advisors LP increased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY)

Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and rai

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob

CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified

CHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "C

DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) has been given a consensus rating of "Hold" by

BMO Capital initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Market Perform rating and a

This milestone reflects PDS Health's continued investment in digital technologies that help practice

XRAY leans on its Return-to-Growth plan, new distributor wins and AI-enabled launches ??? while fore

DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY), the world&

Brings more than 25 years of experience leading transformation, capital deployment, and growth initi

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock?

In turbulent markets, investors turn to dividend-yielding stocks. Here are analyst ratings for high-

Dentsply Sirona (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dent

Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lower

Dentsply Sirona (NASDAQ:XRAY) affirms FY2026 Adj EPS guidance from $1.40-$1.50 to $1.40-$1.50 vs $1.

Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.27 per share which missed the analys

Dentsply Sirona (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dent

Citigroup analyst Daniel Grosslight initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Se

Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicate

Investors turn to dividend-yielding stocks during market turbulence. Benzinga offers latest analyst

Dentsply Sirona (XRAY) reported mixed Q4 results, missing earnings but beating sales estimates. FY20

Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raise

Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outper

A sharp banking selloff gripped Wall Street on Friday, compounding a week dominated by concerns over

Autodesk Inc (ADSK) rose sharply after beating Q4 earnings & issuing strong guidance. Other gain

Wells Fargo analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Equal-Weight and ra

Evercore ISI Group analyst Elizabeth Anderson maintains Dentsply Sirona (NASDAQ:XRAY) with a In-L

Baird analyst Jeffrey Johnson maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises t

Dentsply Sirona (NASDAQ:XRAY) is looking for FY2026 Adj EPS of $1.40-$1.50 vs $1.50 analyst estimate

Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.27 per share which missed the analys